Biogen reported $303.8M in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
ALKERMES ALKS:US $ -35.9M 36.78M
Amgen AMGN:US $ 1476M 423M
Bayer BAYN:GR € 3291M 2130M
Biogen BIIB:US $ 303.8M 64.4M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Gilead Sciences GILD:US $ 19M 363M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Merk MRK:US $ 4310M 552M
Moderna Inc MRNA:US 3.66B 1.21B
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Pfizer PFE:US $ 7863M 4470M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Puma Biotechnology PBYI:US $ -3.4M 7.63M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Seattle Genetics SGEN:US $ -136.49M 38.13M
Teva Pharmaceutical TEVA:IT -955000000 797M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
United Therapeutics UTHR:US $ 239.9M 127.7M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
YTE INCY:US $ 37.99M 525.86M